3 citations
,
January 2025 in “Scientific Reports” This study found that treating asymptomatic or mild COVID-19 with cepharanthine did not significantly reduce the time to a negative test result, though 60 mg/day showed a non-significant trend needing further validation.
3 citations
,
August 2024 in “Frontiers in Immunology” This source reports that understanding how skin cells and immune cells interact may lead to better treatment options for inflammatory skin diseases like psoriasis and atopic dermatitis, emphasizing the role of epithelial-immune microenvironments in disease pathogenesis.
3 citations
,
May 2011 in “Medical Hypotheses” This article proposes that transnasal evaporative cooling could advance understanding of various physiological phenomena, but reports no new clinical results; potential research directions are suggested for this concept.
3 citations
,
April 1989 in “Drug Information Journal” Side effects of drugs can lead to the discovery of new treatments.
2 citations
,
September 2021 in “JCPSP. Journal of the College of Physicians & Surgeons Pakistan” In this study, researchers observed that while there were no significant microvascular abnormalities in the macula of PCOS patients, the parafoveal thickness was significantly increased in most quadrants.
2 citations
,
May 2018 in “Australasian Journal of Dermatology” This article is a letter to the editors about a novel observation regarding chemotherapy-induced alopecia and does not include an abstract with new research results.
2 citations
,
October 2007 in “Kafrelsheikh Veterinary Medical Journal” This study examined the morphological features of buffalo lips, finding that their structure includes distinct layers of skin, muscle, connective tissue, and glands.
1 citations
,
November 2025 in “American Journal of Clinical Dermatology” This study reports that long-term treatment with ritlecitinib is generally well tolerated for up to approximately five years in patients aged 12 and older with alopecia areata, with the safety profile aligning with previous data from the ALLEGRO clinical trials.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” In this study, patients with alopecia areata who didn't initially respond to ritlecitinib at Week 24 showed improved response rates by Week 48, with up to 34% achieving better hair regrowth outcomes.
1 citations
,
January 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” In this study, 60 mg/day of Cepharanthine significantly reduced the time to a negative COVID-19 test among de novo infected patients with good compliance, though 120 mg/day showed no such effect.
1 citations
,
May 2022 in “Голова и шея.” This study concluded that the anesthesia protocol using fentanyl, propofol, cisatracuria besylate, tranexamic acid, atropine, and metoclopramide resulted in the least pain during septoplasty.
October 2025 in “Open Repository of the University of Porto (University of Porto)” This report details a six-month pharmacy internship in Portugal, where the author engaged in hospital and community pharmacy settings, and discusses scientific topics including obesity medication risks and alopecia treatment options. Results and conclusions are not explicitly reported.
October 2024 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.
July 2024 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” This review highlights encouraging findings on platelet-rich plasma's effectiveness in improving skin texture, firmness, and elasticity in aesthetic procedures but emphasizes the need for more standardized protocols and robust clinical trials.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this N=1 case study, a long-term zero-carbohydrate diet adult male experienced an increase in fasting plasma ascorbic acid from 0.1 mg/dL to 2.0 mg/dL within two months of daily 1 g vitamin C supplementation, along with subjective health improvements.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this N=1 case study, researchers observed that a 1 g daily dose of vitamin C successfully elevated plasma vitamin C levels in an adult male following a zero-carbohydrate diet, with reported improvements in some health parameters but no gastrointestinal side effects.
May 2026 in “Biotechnology and Bioengineering” This review discusses recent breakthroughs in 3D bioprinting for hair regeneration, highlighting developments like biomimetic dermal papilla spheroids and follicle organoids, but notes that clinical application is hindered by challenges in integrating vascular and nerve systems and managing hair-cycle dynamics.
December 2025 in “Actas Dermo-Sifiliográficas” This review analyzes the mechanism and evidence supporting the approved use of ritlecitinib, a JAK3/TEC kinase inhibitor, for treating severe alopecia areata in patients aged 12 and older, highlighting its role in the changing therapeutic landscape of this immune-mediated disease.
July 2025 in “Journal of Integrated Health Sciences” In this study, a 32-year-old female with alopecia areata experienced significant symptom relief after receiving traditional Ayurvedic treatments, including Virechana, Pracchana, and Rasayana therapies, alongside external application of Chakramarda. The protocol was reported to be simple, cost-effective, and highly efficacious.
January 2025 in “Diagnostics” In this prospective case-control study, researchers found that women with any phenotype of polycystic ovary syndrome exhibited increased retinal nerve fiber layer and choroidal thickness compared to healthy controls, with changes correlated to body mass index.
In this analysis, JAK inhibitors were found to provide clinically meaningful and durable hair regrowth in pediatric alopecia areata, outperforming traditional therapies with a manageable safety profile.
April 2024 in “Expert opinion on investigational drugs” In this study, JAK inhibitors were reported as safe and effective treatments for moderate-to-severe chronic alopecia areata, although the appropriate duration of treatment remains uncertain, as stopping these medications often results in relapse.
This article reviews the medicinal uses of sweet violet in traditional Persian medicine, highlighting its benefits for conditions like coughing in asthmatic patients, constipation, insomnia, and allergic rhinitis, while noting no special side effects at therapeutic doses.
February 2024 in “Journal of the European Academy of Dermatology and Venereology” In this study, baricitinib for severe alopecia areata showed sustained efficacy over 104 weeks, with most Week-52 responders maintaining significant hair regrowth and some mixed responders improving further with long-term treatment.
October 2023 in “Journal of Indian System of Medicine” This study discusses how Ayurveda approaches the management of premature hair greying differently than contemporary science, emphasizing lifestyle regimens, rejuvenation practices, and the use of herbal drugs rooted in Ayurveda pharmacodynamics.
September 2023 in “Journal of the American Academy of Dermatology” CTP-543 is generally safe for treating alopecia areata.
July 2023 in “SKIN The Journal of Cutaneous Medicine” This study found that some patients with alopecia areata who did not respond to ritlecitinib treatment by Week 24 achieved a positive response with continued therapy by Week 48, with tolerable side effects.
June 2023 in “Medeniyet medical journal” This study found that while the macular, retinal nerve fiber layer, and retinal layers' thickness were similar between alopecia areata patients and controls, the choroidal thickness was significantly thicker in the alopecia areata group, suggesting potential inflammation-related changes.
June 2020 in “The journal of investigative dermatology/Journal of investigative dermatology” In this study, mice fed various high-fat diets showed changes in dermal white adipose tissue lipid composition, with decreases in essential omega-3 fatty acids, which are important for skin health.
July 2019 in “Facial Plastic Surgery Clinics of North America” New techniques and technologies are improving facial plastic and reconstructive surgery.